NCT01852162View on ClinicalTrials.gov

Pharmacodynamic Effects of Dabigatran in Patients on Dual Antiplatelet Therapy

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

February 28, 2014

Conditions
Coronary Artery Disease
Interventions
DRUG

Dabigatran

Dabigatran 150mg

DRUG

Placebo

Matching placebo tablets

Trial Locations (1)

32209

University of Florida, Jacksonville

All Listed Sponsors
lead

University of Florida

OTHER

NCT01852162 - Pharmacodynamic Effects of Dabigatran in Patients on Dual Antiplatelet Therapy | Biotech Hunter | Biotech Hunter